Journal of Virology

Medical research

No two kinds of retroviruses look—or act—the same

In the most comprehensive study of its kind, researchers in the Institute for Molecular Virology and School of Dentistry at the University of Minnesota report that most types of retroviruses have distinct, non-identical virus ...

Diseases, Conditions, Syndromes

Researchers discover mechanism for Rift Valley fever virus infection

Viruses can't live without us—literally. As obligate parasites, viruses need a host cell to survive and grow. Scientists are exploiting this characteristic by developing therapeutics that close off pathways necessary for ...

Diseases, Conditions, Syndromes

Researchers shed light on pathway from virus to brain disease

Why people on immunosuppressant drugs for autoimmune conditions have a higher incidence of an often-fatal brain disease may be linked to a mutation in a common virus, according to researchers at Penn State College of Medicine.

Diseases, Conditions, Syndromes

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

Diseases, Conditions, Syndromes

Scientists seek to improve flu vaccine for the very young

Scientists at the University of Rochester School of Medicine and Dentistry have discovered a way to make a nasal spray flu vaccine safer for those who are at greatest risk of catching the flu, particularly infants under the ...

Diseases, Conditions, Syndromes

Study shows high frequency of spontaneous mutation in Ebola virus

In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat ...

Immunology

Compound found to trigger innate immunity against viruses

Research from UW Medicine and collaborators indicates that a drug-like molecule can activate innate immunity and induce genes to control infection in a range of RNA viruses, including West Nile, dengue, hepatitis C, influenza ...

page 7 from 17